TE_125
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MLT1A0 |
|---|---|
| TE superfamily | MaLR |
| TE order | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 10.99 |
| Counts of samples | TCGA_tumor:38; TCGA_normal:0; GTEx:3 |
| TSS | chr1(-):14078636 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_125.1 | - | Intergenic | Non-coding | Non-coding | chr1(-):14076257,14076277,14077428,14077604,14078546,14078637 |
| teRNA_125.2 | - | Intergenic | Non-coding | Non-coding | chr1(-):14077282,14077302,14077428,14077604,14078546,14078637 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
